| |
 |
Drugs, Gene Therapy, Devices, Diagnostics Biologics |
 |
Communications with all major Health Authorities
|
 |
Development of regulatory and drug development
strategy |
 |
Global regulatory affairs |
 |
Collation and organization of health authority
correspondence |
 |
Function as consultant VP Regulatory Affairs
|
 |
Appeals |
 |
Organization of dispute resolution process
|
 |
Perform critical reviews of prepared submissions
|
 |
European clinical trial applications |
 |
CTAs, INDs, CTXs, NDAs, CTDs, MAAs |
 |
Strategic planning |
 |
Annual Report preparation (INDs, approved
products) |
 |
Summary Basis of Approval review and analysis
|
| |
|
| |
 |
Medical writing |
 |
Protocol design |
 |
Clinical trial design |
 |
Clinical trial monitoring (through collaborator
monitors throughout the country) and abroad |
|
|
| |
 |
Development of quality strategy |
 |
Development of quality systems |
 |
Training of senior management in quality concepts |
 |
Audits of suppliers, manufacturers, toxicology
houses, etc |
 |
Preparation for pre-approval inspections |
 |
Performance of mock-FDA inspections |
| |
|
| |
 |
Development of corporate strategy on safety |
 |
Preparation of safety reports |
 |
Liaison with investigative sites and CROs for development
of SOPs for drug safety |
 |
Training in drug safety concepts |
| |
|
| |
 |
Manufacturing strategy for drug substance and drug product |
|